| |
About Alvogen:
Alvogen is a Specialty Generics company focused on developing,
producing and marketing complex, high value generic drugs;
providing access to such medications; and improving the quality
of life for millions of Americans. In seeking to establish
a leadership position in an emerging “third” category
of drugs beside branded pharmaceuticals and commoditized generics,
Alvogen is focused on:
- Harnessing our world-class manufacturing
capabilities
- Expanding production capabilities
to further support high-tech manufacturing capabilities
- Leveraging the extensive portfolio,
pipeline and resources of our SuMas Pharmaceutical Group
affiliates
- Expanding development capabilities
through partnerships, alliances, mergers and acquisitions
Alvogen At a Glance
- U.S.-based Specialty Generics company
- Member of the multinational SuMas
Pharmaceutical Group (SPG)
- Six manufacturing sites in the U.S.,
Middle East and North Africa
- More than 1,800 employees worldwide
- More than 400 products in over 30
markets
- Projected annual sales of $200
million
|
